$9.09
-0.38-4.01%
At close: Nov 11, 4:00 PM EST
$9.09
-0.38-4.01%
Pre-Market: 4:00 AM EST
Benitec Biopharma Inc (BNTC) Stock Price, Quote, News & History
BNTCNASDAQ
Latest clinical data on BB-301 treatment for OPMD. Positive results in swallowing improvement. Benitec Biopharma announces interim findings and $40 million PIPE...
You can purchase shares of Benitec Biopharma (NASDAQ:BNTC) through any online brokerage.
Other companies in Benitec Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Benitec Biopharma has a consensus price target of $22.25.
The stock price for Benitec Biopharma (NASDAQ: BNTC) is $9.09 last updated November 12, 2026 at 4:00 PM EST.
There are no upcoming dividends for Benitec Biopharma.
Benitec Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Benitec Biopharma.
Benitec Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no...
